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To the Editor:
We read with great interest the article entitled “The unexpected
role of copy number variations in juvenile myoclonic epilepsy” by
Helbig I. et al. [1] published in the supplemental special issue “Juve-
nile myoclonic epilepsy: What is it really?” [July 2013] of this jour-
nal. We thought that it would be appropriate to report the 22q11.2
chromosome as an additional proposed critical region for juvenile
myoclonic epilepsy (JME) in order to raise awareness that 22q11.2
distal rearrangements may not be so uncommon in populations
with epilepsy and to suggest the need to further study individuals
with both microdeletions and duplications at 22q11.2.
In fact, epileptic seizures are frequent in chromosomal disorders, but
only a few of these disorders are associated with speciﬁc seizure and
EEG patterns [2–4]. Thus, it is assumed that causative chromosomal
aberrations offer the opportunity to identify genes which may be in-
volved in idiopathic epilepsies [3]. In patients with JME, several autoso-
mal genes have been reported to show heterozygous (CACNB4, CLCN2,
GABRA1, EFHC1) [5–8] and, in a single case, homozygous mutations
(GABRD) [9]. Further loci have been linked to chromosomes 5q, 6p,
and 15q [10–12]. However, most forms of JME seem to follow poly- or
oligogenic inheritance. The 22q11.2 chromosome has long been impli-
cated in several genomic disorders with neurological impairment
including DiGeorge/velocardiofacial syndrome (DGS/VCFS), der(22)
syndrome, and cat-eye syndrome (CES), which are associated with
either decreased or increased gene dosage [13–16]. Recent evidence
presumes that these different congenital anomaly disorders share
a physical region of overlap containing chromosome 22-speciﬁc low-
copy repeats (LCRs) composed of a complex modular structure with a
high degree of sequence homology (N95%) over large stretches within
the repeats. Low-copy repeats predispose to homologous recombina-
tion events andmediatemeiotic nonallelic homologous recombinations
(NAHR) resulting in genomic rearrangements of the 22q11.2 chromo-
some, including microdeletion and duplication [16–18]. While the
cat-eye and der(22) syndromes are rare disorders characterized by du-
plications (tetrasomy and trisomy, respectively) of part of 22q11.2; on
the contrary, 22q11.2 microdeletions, associated with DGS/VCFS, occur
more often in the general population with an estimated frequency of
1/4000–6000 live births [19]. Even though recent data suggest that
the frequency of 22q11.2 microduplications could be approximately
half that of the deletions, relatively few duplications have been detected
among human genomic disorders. Up to now, about 100 patients have
been reported, and a high frequency of familial duplications has been
detected [20]. This discrepancy may be due, in part, to the remarkable
phenotypic variability of the duplications [21,22], which may compli-
cate the clinical recognition of the corresponding syndromes.
So far, several studies focused on the potential connection between
certain epilepsy phenotypes and the 22q11.2 locus. Kao et al. [23]1525-5050/$ – see front matter © 2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.yebeh.2013.08.008reported a signiﬁcantly increased prevalence of unprovoked seizures
in individuals with del(22)(q11.2) and suggested generalized epilepsy
as a primary manifestation of the disorder. Coppola et al. [24] described
twopatientswith a del(22)(q11.2) and an epilepsy resemblingRolandic
epilepsy. Both patients had sporadic Rolandic or occipital partial-onset
seizures with clinical and electroencephalographic features of benign
idiopathic childhood epilepsy. Baralle et al. [25] reported on a mother
and her son who both had a 22q11.2 microdeletion; the mother
presented with a tremor-like myoclonic movement disorder affecting
the head, trunk, and limbs since infancy. Furthermore, there were sin-
gle reports of patients carrying the deletion or the duplication and pre-
senting with atypical absences [26] or generalized seizures [27–29].
Finally, Lemke et al. [30] and Piccione et al. [31] described two different
patients with a diurnal pattern of myoclonias, generalized tonic–clonic
seizures, and pathologic EEG with generalized spike waves (which are
characteristic of JME) and respectively affected by 22q11.2microdeletion
and duplication.
Thus, based on the abovementioned features, although the
syndrome's phenotype is well known to include epileptic seizures,
putative epilepsy-causing genes are predicted within the 22q11.2
band. Therefore, a latent predisposition to seizures/JME, triggered
by chromosomal imbalance and a decreased or increased gene dos-
age effect, could be assumed as well. In this view, it could be relevant
to clarify the not yet known role of the Rab36 gene at the 22q11.22
sub-band and its Ras-associated protein Rab36 currently localized
by immunoﬂuorescence studies at the Golgi body and hypothesized to
be involved, like some other Rab family proteins, in vesicular transport
[32]. Recently, Chen et al. [33] have shown that the overexpression of
Rab36 induced late endosome and lysosome clustering around the
Golgi apparatus and that Rab36 can also interact with Rab-interacting
lysosomal proteins. These data suggest that the haploinsufﬁciency or
the overexpression of Rab36may interfere in neurotransmitter process-
ingwith an erroneous trafﬁckingmechanismof release or other forms of
unregulated secretion. Furthermore, this would seem to be mimicking
and amplifying the recently recognized mechanism of the Rab39B gene
that codiﬁed Golgi-associated GTPase with a critical role in vesicular
trafﬁcking, development of neurons, and human intellectual abilities.
Rab39B mutations are, in fact, demonstrated to be responsible for a
new X-linked syndrome characterized by milder phenotype, mental
retardation, and epilepsy [34]. In conclusion, emphasizing the idea that
the 22q11.2 chromosome should be considered a new critical region
for epilepsy/JME, we propose that only by widening the scope of the
patients tested and further investigating the function of the RAB36
gene will we gain a better understanding of the JME's yet unrecognized
cryptogenetic/idiopathic pattern.References
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